Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5166964 | 1.00 | CYP2C9 (0.48) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL1813388 | 0.91 | MGLL (0.40) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL2883392 | 0.91 | MGLL (0.40) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL6452615 | 0.87 | PAX8 (0.38) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL6452617 | 0.87 | PAX8 (0.38) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL9226984 | 0.87 | CYP2C9 (0.51) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL9226977 | 0.87 | CYP2C9 (0.51) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL7506574 | 0.85 | CYP2C9 (0.55) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL8027625 | 0.85 | CYP2C9 (0.55) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL28560659 | 0.85 | TAAR1 (0.55) | TAAR1ESR2PAX8CYP17A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1310542-B1 | Liquid crystalline compound, medium and display | MERCK PATENT GMBH (DE) | 2007-04-18 | — | — | EP | disclosed |
| US-6753046-B2 | ELECTROOPTIC DISPLAYING | MERCK PATENT GMBH (DE) | 2004-06-22 | — | — | US | disclosed |
| US-20030190436-A1 | Liquid crystalline compound, medium and display | MERCK PATENT GMBH (DE) | 2003-10-09 | — | — | US | disclosed |
| EP-1310542-A1 | Liquid crystalline compound, medium and display | MERCK PATENT GmbH (DE) | 2003-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030190436-A1 | Liquid crystalline compound, medium and display | OCIAD1, OCIAD2, CFB | CYP2C9 3133/4885ALDH1A1 1308/4885LMNA 2011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.